Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
Public ClinicalTrials.gov record NCT02684578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
METforMIN: Metformin Administration for the Minimization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration
Study identification
- NCT ID
- NCT02684578
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of California, San Francisco
- Other
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- Metformin Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016
- Primary completion
- Mar 31, 2022
- Completion
- Sep 30, 2022
- Last update posted
- Jun 8, 2023
2016 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Davis | Davis | California | 95616 | — |
| Palo Alto Veteran Affairs Medical Center | Palo Alto | California | 94304 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95819 | — |
| San Francisco Veteran Affairs Medical Center | San Francisco | California | 94121 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| California Retina Consultants | Santa Maria | California | 93454 | — |
| North Bay Vitreoretinal Consultants | Santa Rosa | California | 95403 | — |
| Retina Health Center | Fort Myers | Florida | 33907 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Austin Retina Associates | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02684578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02684578 live on ClinicalTrials.gov.